Our Research

At the Jacobs School, we advance research and discovery to improve health for all. Our multidisciplinary research advances basic and clinical science; we translate those discoveries into clinical care that improves health in our communities. With our eyes on the future, we are increasing the number of students and trainees who pursue careers in research, biomedical science and academic medicine.

Our Research Accomplishments

Recent Publications

Recent Research Funding

  • A Multicenter Randomized Controlled Trial of Best Available Therapy versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis, BEAT-MS (Protocol ITN077AI).Bianca Weinstock-Guttman (Principal Investigator). National Institute of Allergy & Infectious Diseases (NIAID), Division of Allergy, Immunology &Transplantation (DAIT) via a subaward. 1/1/2020-12/1/2026.
  • Synaptic and Genetic Mechanisms of Sex-Specific Effects of Stress.Zhen Yan (Principal Investigator). NIH. $2,621,841. 4/1/2021-1/1/2026.
  • A 5-Year Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions.Heather Lehman (Principal Investigator). TARGET PharmaSolutions, Inc. 1/1/2020-12/1/2025.
  • A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod (RPC-1063).Bianca Weinstock-Guttman (Principal Investigator). Celgene International. 6/1/2020-12/1/2025.